Literature DB >> 21346603

Alteration of local microflora and α-defensins hyper-production in colonic adenoma mucosa.

Cristiano Pagnini1, Vito D Corleto, Maria Luisa Mangoni, Emanuela Pilozzi, Maria Simona Torre, Rodolfo Marchese, Antonella Carnuccio, Emilio Di Giulio, Gianfranco Delle Fave.   

Abstract

BACKGROUND AND AIM: Gut flora/host interactions are fundamental for the maintenance of homeostasis. Evidence of possible regulatory effect of commensal bacteria on proliferative disorders of the colon is mounting. In this study, we explored the hypothesis that precancerous lesions, such as adenomas, present alteration of the local microflora and lead to an overproduction of antibacterial molecules of the innate immunity, namely α-defensins. Thus, the host-bacteria misbalance could represent a potential procarcinogenic factor.
METHODS: Biopsies from adenomatous polyps and normal mucosa, in the rectum-sigmoid colon, were collected from 51 patients. Concentration of mucosal bacteria was evaluated by real-time polymerase chain reaction after extraction of total DNA. Total RNA was also extracted, and the defensin α-1, defensin-5, and defensin-6 gene expressions were evaluated by real-time polymerase chain reaction. Immunohistochemical study has been carried out to evaluate protein production and location. Antibacterial activity of adenomatous polyps mucosa was evaluated in vitro.
RESULTS: Biopsies from adenomatous polyps had a significant relative reduction of mucosa adherent bacteria compared with normal tissue (20-fold relative reduction, P<0.05). Concomitantly, α-defensin expression and production were significantly increased in adenomas. Adenoma mucosa showed increased antibacterial activity in vitro compared with normal mucosa.
CONCLUSIONS: Microflora dysbiosis occurs at the mucosal surface in colonic adenomas, and may represent a potential factor for dysplastic cell proliferation. Further studies are needed to confirm and define the role of this mechanism in colon carcinogenesis and the potential applications in the clinical setting.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21346603     DOI: 10.1097/MCG.0b013e31820abf29

Source DB:  PubMed          Journal:  J Clin Gastroenterol        ISSN: 0192-0790            Impact factor:   3.062


  15 in total

Review 1.  The gastrointestinal microbiota and colorectal cancer.

Authors:  Temitope O Keku; Santosh Dulal; April Deveaux; Biljana Jovov; Xuesong Han
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2014-12-24       Impact factor: 4.052

2.  Effect of bifidobacterium on defensin-5 expression in intestinal injury of preweaning rats.

Authors:  Wei Wang; Shu-Fen Yang; Li-Hong Ren; Xiu-Xiu Zhang; Shui-Lian Yu
Journal:  World J Gastroenterol       Date:  2015-03-07       Impact factor: 5.742

Review 3.  Gut microbiota: an Indicator to Gastrointestinal Tract Diseases.

Authors:  Trupti Patel; Priyanjali Bhattacharya; Suvrajit Das
Journal:  J Gastrointest Cancer       Date:  2016-09

4.  Downregulation of hematopoietic MUC1 during experimental colitis increases tumor-promoting myeloid-derived suppressor cells.

Authors:  Tze Wei Poh; Cathy S Madsen; Jessica E Gorman; Ronald J Marler; Jonathan A Leighton; Peter A Cohen; Sandra J Gendler
Journal:  Clin Cancer Res       Date:  2013-07-19       Impact factor: 12.531

5.  Microbial dysbiosis and colon carcinogenesis: could colon cancer be considered a bacteria-related disease?

Authors:  Iradj Sobhani; Aurelien Amiot; Yann Le Baleur; Michael Levy; Marie-Luce Auriault; Jeanne Tran Van Nhieu; Jean Charles Delchier
Journal:  Therap Adv Gastroenterol       Date:  2013-05       Impact factor: 4.409

Review 6.  Current Understanding of Dysbiosis in Disease in Human and Animal Models.

Authors:  Arianna K DeGruttola; Daren Low; Atsushi Mizoguchi; Emiko Mizoguchi
Journal:  Inflamm Bowel Dis       Date:  2016-05       Impact factor: 5.325

7.  Systemic folate status, rectal mucosal folate concentration and dietary intake in patients at differential risk of bowel cancer (The FAB2 Study).

Authors:  Elizabeth A Williams; Mark Welfare; Alison Spiers; Marilyn H Hill; Wendy Bal; Eileen R Gibney; Yvonne Duckworth; Hilary J Powers; John C Mathers
Journal:  Eur J Nutr       Date:  2012-12-28       Impact factor: 5.614

8.  Mucin depleted foci, colonic preneoplastic lesions lacking Muc2, show up-regulation of Tlr2 but not bacterial infiltration.

Authors:  Angelo Pietro Femia; Alexander Swidsinski; Piero Dolara; Maddalena Salvadori; Amedeo Amedei; Giovanna Caderni
Journal:  PLoS One       Date:  2012-01-05       Impact factor: 3.240

9.  Development and validation of a highly sensitive urine-based test to identify patients with colonic adenomatous polyps.

Authors:  Haili Wang; Victor Tso; Clarence Wong; Dan Sadowski; Richard N Fedorak
Journal:  Clin Transl Gastroenterol       Date:  2014-03-20       Impact factor: 4.488

10.  Novel Testing Enhances Irritable Bowel Syndrome Medical Management: The IMMINENT Study.

Authors:  Kelly Parsons; Julius Goepp; Bryan Dechairo; Elizabeth Fowler; Nathan Markward; Patrick Hanaway; Teresa McBride; Darryl Landis
Journal:  Glob Adv Health Med       Date:  2014-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.